Clinical Trials Browser

Phase 4 × Filgrastim × Clear all

NCT05753618 2026-02-09

REaCT-OGF

Phase 4 Recruiting

Breast Neoplasms

NCT04781959 2025-03-21

A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy

Phase 4 Completed

Breast Neoplasms

NCT06763666 2025-01-08

CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML

Phase 4 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06145321 2024-09-19

Continuous Versus Bolus Administration of G-CSF in Children With Cancer

Phase 4 Active not recruiting

Neoplasms, Neutropenia

NCT02816112 2020-05-27

REaCT-TC2

Phase 4 Completed

Early Stage Breast Cancer

NCT01731886 2020-02-05

Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma

Phase 4 Completed

60 enrolled 14 charts

Multiple Myeloma

NCT00003398 2019-10-17

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Phase 4 Completed

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Anemia, Blast Crisis, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Leukemia, Leukemia, Megakaryoblastic, Acute, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating

NCT02816164 2019-09-06

REaCT-G2

Phase 4 Completed

Early Stage Breast Cancer

NCT02805153 2016-06-20

PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy

Phase 4 Completed

Breast Neoplasms

NCT01222819 2016-04-06

G-CSF

Phase 4 Terminated

Classical hematologyOther hematologic neoplasm

Leukemia, Febrile Neutropenia

NCT01164475 2014-02-25

Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms

Phase 4 Completed

61 enrolled 19 charts

Lymphoma, Non-Hodgkin

NCT00030758 2013-08-07

Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer

Phase 4 Unknown

Breast Neoplasms, Neutropenia